无菌便微生物种植增强了性结肠炎患者的抗炎T细胞反应
Anton Chechushkov1,2, Pavel Desyukevich1, Timir Yakovlev1
1Federal State Public Scientific Institution "Institute of Chemical Biology and Fundamental Medicine", Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
International journal of molecular sciences
|February 10, 2024
概括
这项研究表明,将无菌便过物移植到性结肠炎患者身上,可以诱导有益的抗炎性免疫反应. 这种疗法会改变T-辅助细胞的活性,促进愈合并改善生活质量.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 微生物组研究的研究.
背景情况:
- 性结肠炎是一种慢性,免疫介导的疾病,原因不明,严重影响患者的生活质量.
- 目前的治疗主要使用抗炎药物,缺乏针对特定疾病机制的有针对性的方法.
研究的目的:
- 调查无菌便液移植对诱导性结肠炎患者抗炎性免疫机制的影响.
- 为了评估手术后T-辅助细胞反应和细胞因子生产的变化.
主要方法:
- 患有性结肠炎的患者接受了来自健康捐赠者的无菌便过物的移植.
- 在移植前和移植后评估T辅助细胞的反应性和细胞因子 (IL-10,IL-4) 的产生,以对便过物的反应进行评估.
主要成果:
- 移植诱导的抗原特异性T辅助细胞产生了抗炎IL-10.
- 治疗前的细胞表现出较低的反应性,并产生促炎性IL-4.
- 观察到T-辅助剂反应的抗炎转变,在术后至少持续了三个月.
结论:
- 无菌便液移植可以调节性结肠炎的免疫反应.
- 该程序促进了抗炎T辅助细胞的特征,表明性结肠炎的治疗潜力.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
145
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
145
Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
164
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
164
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
119
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
119
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
334
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
334
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127


